Opinion|Podcasts|July 1, 2024

Addressing Suboptimal Anti-VEGF Response in Neovascular AMD and DME

Listen
0:00 / 0:00

Key Takeaways

  • Novel therapies, including targeted treatments and immunotherapy, have improved response rates and survival in lung cancer brain metastases.
  • Advanced imaging techniques are essential for monitoring treatment efficacy and disease progression in patients.
SHOW MORE

A panel of ophthalmologists discuss strategies for managing AMD and DME patients who exhibit suboptimal responses to their current anti-VEGF therapy.

To watch the video series component of this episode, click here.

1:12 Suboptimal Response
6:42 Treatment Strategy
11:22 Response to New Therapies
14:12 Imaging for Monitoring
18:42 Role of Ang-2


Latest CME